pharma news today glp-1 A new weight-loss pill- Foundayo, is making global headlines, with many claiming it could challenge injectable drugs like Wegovy, Ozempic and Mounjaro. But is that really true?, In this video, we GLP-1 Pipeline Update: August 2025
Description
Lancet 2016;387:67990.ArticlePubMed 21
Key Insights Mounjaro reached 80 crore in sales for September 2025, a 43% increase month-on-month, securing the number 2 spot by sales, just behind Augmentin and surpassing the popular antacid Pan
From a programmatic standpoint, MEDVi emphasizes predictability and oversight rather than volume-based distribution
Scott's Perspective Every year, we see exciting advances in obesity medicine , and Retatrutide is one of the most promising medications currently being studied
Orforglipron Orforglipron, another oral GLP-1RA has being studied extensively for the management of T2DM and Obesity
JAMA (2015) 314(7):68799
